World's Best Scientists 2026 revealed!
Lennart Minthon

Lennart Minthon

D-Index & Metrics

Medicine

D-Index
103
Citations
36794
World Ranking
7404
National Ranking
148

Overview

Lennart Minthon is affiliated with Lund University in Sweden and focuses primarily on research within the field of Medicine. Their work spans several subfields, including Psychiatry and Mental Health, Physiology, Pediatrics, Perinatology and Child Health, Cardiology and Cardiovascular Medicine, and Critical Care and Intensive Care Medicine.

The central topics addressed in their research cover Dementia and Cognitive Impairment, Alzheimer's Disease research and treatments, Pharmacological Effects and Toxicity Studies, Heart Failure Treatment and Management, and cognitive disorders encountered in Intensive Care Units.

Their recent publications include:

  • Mortality in patients with behavioural and psychological symptoms of dementia: a registry-based study, 2020, Aging & Mental Health
  • Cognitive test results are associated with mortality and rehospitalization in heart failure: Swedish prospective cohort study, 2020, ESC Heart Failure

Frequent co-authors collaborating with Lennart Minthon include:

  • Katarina Nägga
  • Vanja Bränsvik
  • Eva Granvik
  • Peter Nordström
  • Hannes Holm

The publication venues where their work has appeared include Aging & Mental Health and ESC Heart Failure.

Best Publications

  • Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study

    Oskar Hansson;Oskar Hansson;Henrik Zetterberg;Peder Buchhave;Peder Buchhave;Elisabet Londos;Elisabet Londos

  • CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

    Niklas Mattsson;Henrik Zetterberg;Oskar Hansson;Niels Andreasen

  • Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

    Sandip Ray;Markus Britschgi;Charles Herbert;Yoshiko Takeda-Uchimura

  • Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study

    Pieter Jelle Visser;Pieter Jelle Visser;Frans Verhey;Dirk L Knol;Philip Scheltens

  • Cerebrospinal Fluid β-Amyloid(1-42) in Alzheimer Disease: Differences Between Early- and Late-Onset Alzheimer Disease and Stability During the Course of Disease

    Niels Andreasen;Camilla Hesse;Pia Davidsson;Lennart Minthon

  • Evaluation of CSF-tau and CSF-Abeta42 as diagnostic markers for Alzheimer disease in clinical practice

    Niels Andreasen;Lennart Minthon;Pia Davidsson;Eugeen Vanmechelen

  • 18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment : a phase 2 trial.

    Rik Vandenberghe;Rik Vandenberghe;Koen Van Laere;Adrian Ivanoiu;Eric Salmon

  • Cerebrospinal Fluid Levels of β-Amyloid 1-42, but Not of Tau, Are Fully Changed Already 5 to 10 Years Before the Onset of Alzheimer Dementia.

    Peder Buchhave;Lennart Minthon;Henrik Zetterberg;Åsa K. Wallin

  • Interleukin-6 Is Elevated in the Cerebrospinal Fluid of Suicide Attempters and Related to Symptom Severity

    Daniel Lindqvist;Shorena Janelidze;Peter Hagell;Sophie Erhardt

  • Memantine in patients with Parkinson's disease dementia or dementia with Lewy bodies: a double-blind, placebo-controlled, multicentre trial

    Dag Aarsland;Dag Aarsland;Clive Ballard;Zuzana Walker;Zuzana Walker;Fredrik Bostrom

  • Diagnosis-Independent Alzheimer Disease Biomarker Signature in Cognitively Normal Elderly People

    Geert De Meyer;Fred Shapiro;Hugo Vanderstichele;Eugeen Vanmechelen

  • Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease

    Jacob W. Vogel;Yasser Iturria-Medina;Olof T. Strandberg;Ruben Smith

  • Accuracy of a Panel of 5 Cerebrospinal Fluid Biomarkers in the Differential Diagnosis of Patients With Dementia and/or Parkinsonian Disorders

    Sara Hall;Annika Öhrfelt;Radu Constantinescu;Ulf Andreasson

  • Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study

    Bengt Winblad;Lena Kilander;Sture Eriksson;Lennart Minthon

  • CSF Aβ42/Aβ40 and Aβ42/Aβ38 ratios: better diagnostic markers of Alzheimer disease

    Shorena Janelidze;Henrik Zetterberg;Niklas Mattsson;Sebastian Palmqvist

  • Plasma tau levels in Alzheimer's disease

    Henrik Zetterberg;Henrik Zetterberg;David Wilson;Ulf Andreasson;Lennart Minthon

  • Detailed comparison of amyloid PET and CSF biomarkers for identifying early Alzheimer disease

    Sebastian Palmqvist;Henrik Zetterberg;Niklas Mattsson;Per Johansson

  • Accuracy of Brain Amyloid Detection in Clinical Practice Using Cerebrospinal Fluid β-Amyloid 42: A Cross-Validation Study Against Amyloid Positron Emission Tomography.

    Sebastian Palmqvist;Henrik Zetterberg;Kaj Blennow;Susanna Vestberg

  • Standardization of measurement of beta-amyloid(1-42) in cerebrospinal fluid and plasma.

    H Vanderstichele;E Van Kerschaver;C Hesse;P Davidsson

  • Safety, tolerability, and antibody response of active Aβ immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study

    Bengt Winblad;Niels Andreasen;Lennart Minthon;Annette Floesser

Frequent Co-Authors

Kaj Blennow
Kaj Blennow University of Gothenburg
Henrik Zetterberg
Henrik Zetterberg University of Gothenburg
Oskar Hansson
Oskar Hansson Lund University
Elisabet Londos
Elisabet Londos Lund University
Harald Hampel
Harald Hampel Eisai (United States)
Anders Wallin
Anders Wallin University of Gothenburg
Niels Andreasen
Niels Andreasen Karolinska University Hospital
Pieter Jelle Visser
Pieter Jelle Visser Amsterdam University Medical Centers
Lars-Olof Wahlund
Lars-Olof Wahlund Karolinska Institute
Erik Stomrud
Erik Stomrud Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a medical degree is just one of many routes into the healthcare field. If you’re considering alternative or complementary pathways, several online programs offer flexibility and specialized training.

For those interested in healthcare administration and office work, medical billing and coding schools that accept financial aid provide accessible options to enter the workforce quickly. This career path is ideal for individuals seeking administrative roles without direct patient care responsibilities.

If you’re already a licensed practical nurse and hope to advance, explore lpn to rn programs without teas test. These bridge programs can help you transition smoothly into Registered Nurse roles, often with fewer standardized testing requirements.

Aspiring leaders and managers in healthcare may consider healthcare administration programs for training in management, policy, and operations—a field with diverse career options beyond clinical practice.

Lastly, registered nurses aiming for advanced practice should review adn to fnp programs to earn their master’s degree and qualify as Family Nurse Practitioners. These flexible, online bridge programs can help accelerate your professional growth and open doors to advanced clinical roles.

Best Scientists Citing Lennart Minthon

Trending Scientists

Recently Published Articles